The company has discovered a series of novel peptides with prominent tissue protective effects in conditions of ischemia-reperfusion, that may be developed into an important new category of drugs to treat acute myocardial ischemia (MI), reperfusion injury as well as for surgical preconditioning.
+46 70 666 50 95
